Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors. - Archive ouverte HAL Access content directly
Journal Articles Future Medicinal Chemistry Year : 2013

Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors.

Abstract

HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) represent one of the most significant classes of drugs for the treatment of AIDS/HIV infection. Over the past two decades several potent arylsulfone-based HIV-1 NNRTIs and related analogs have been developed. This review provides an essential overview of the structure-activity relationships of the arylsulfone-based HIV-1 NNRTIs. Furthermore, structural information useful for the design and development of new sulfur containing NNRTIs with enhanced antiretroviral activity against HIV-1 wild type and clinically relevant drug resistant HIV-1 mutant strains will be discussed.
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

pasteur-01054201 , version 1 (05-08-2014)

Identifiers

Cite

Valeria Famiglini, Antonio Coluccia, Andrea Brancale, Sveva Pelliccia, Giuseppe La Regina, et al.. Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors.. Future Medicinal Chemistry, 2013, 5 (18), pp.2141-56. ⟨10.4155/fmc.13.174⟩. ⟨pasteur-01054201⟩

Collections

RIIP RIIP_FCB
21 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More